Feasibility of At-Home Chair-Based Resistance Band Training to Improve Balance, Strength, and Bone Density in Older Adults

NCT06671847 | Not Yet Recruiting FDA Device

• 1 other identifier: HSC-MS-24-0485
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to determine the feasibility of implementing a 24-week at-home chair-based resistance band training intervention, to determine effectiveness of a the a 24-week at-home chair-based resistance band training intervention in improving body composition and to determine the effectiveness of a 24-week at-home chair-based resistance band training intervention in improving physical performance in adults 50 years and older, receiving care at the UT Physicians Center for Healthy Aging.

Conditions

Sarcopenic Obesity

Keywords

chair-based resistance band exercise

Outcome Measures

Primary Outcomes (1)

• Feasibility as assessed by the number of people who are able to follow the prescribed exercise regimen at least 50 percent of the time

  end of study (24 weeks from baseline)

Secondary Outcomes (20)

• Change in body fat

  baseline,6-months

• Change in bone mineral density (BMD) of the femoral neck and lumbar spine

  baseline, 1 year from baseline

• Handgrip strength

  baseline

• Handgrip strength

  1-month

• Handgrip strength

  3-months

Study Arms (1)

Chair-based resistance band training

EXPERIMENTAL

Device: THERABand resistance exercise bands

Interventions

THERABand resistance exercise bands DEVICE

The training will be performed using THERABand resistance exercise bands.Participants will be instructed to perform the exercises twice per week at home, for the 24 weeks duration. Each exercise session will entail 1 set of 15 repetitions of 9 different exercises

Chair-based resistance band training

Eligibility Criteria

• Age: 50 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• English-speaking
• receive care at the UT Physician Center for Healthy Aging

You may not qualify if:

• inability to provide informed consent on their own
• presence of obvious signs of cognitive decline
• a diagnosis of dementia and inability to come to the clinic for the scheduled study visits.

Sponsors & Collaborators

• The University of Texas Health Science Center, Houston: lead

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77479, United States

Location

Study Officials

• Nahid Rianon, MBBS, DrPH

  The University of Texas Health Science Center, Houston

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Nahid Rianon, MBBS,DrPH

CONTACT

(713) 500-5106; Nahid.J.Rianon@uth.tmc.edu

Jude des Bordes, MBChB, DrPH

CONTACT

(713) 500-6029; Jude.K.desBordes@uth.tmc.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Dean for Faculty Affairs

Study Record Dates

• First Submitted: November 1, 2024
• First Posted: November 4, 2024
• Study Start: January 1, 2025
• Primary Completion: March 31, 2026
• Study Completion (Estimated): September 30, 2026
• Last Updated: November 4, 2024

Record last verified: 2024-11

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)